Formation Bio is a tech-driven pharma company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes all aspects of drug development, ...
Vimeo just got hit by a brutal round of layoffs, according to a report by Business Insider. Staffers are posting on various social media sites that the layoffs have impacted most of the company, ...
Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily. The private equity model has struck again ...
Once upon a time, there was an online video platform called Vimeo that internet users knew as the high-brow alternative to YouTube. If YouTube was known for its vloggers and amateur comedy skits, ...
Vimeo just got hit by another round of layoffs, and it sounds like it was a big one. Business Insider reported earlier this week that the video hosting site had cut jobs across its global workforce.
Vimeo is laying off staffers globally in a new round of cuts. The job cuts arrived a few months after tech holding company Bending Spoons bought Vimeo. It's Vimeo's second round of layoffs since ...
Hosted on MSN
Vimeo Merges, Delists from Nasdaq, Board Resigns
Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
The internet is being swallowed by fake videos. Vimeo is doubling-down on real ones. The video platform — known as YouTube’s ad-free, artist-friendly counterpart — is not playing the generative game.
Vimeo (VMEO) shares ticked slightly lower on Friday, closing at $7.78. Despite a modest dip, the stock is still up around 60% over the past year, reflecting steady investor interest in the video ...
Generation Bio is shedding 90% of its workforce after the biotech acknowledged it’s unlikely to find the cash to take its lipid nanoparticle tech into the clinic. The Massachusetts-based company has ...
Dash Bio has captured new venture funding after drawing pharmaceutical customers to a platform that uses robotics to crack a bottleneck that slows drug development. Former employees of biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results